Illuminating Success in mRNA-Based Therapeutics
Advancing Innovation, Accelerating Delivery for Patient Impact
Closing notice: mRNA-Based Therapeutics Searchlight network
A chapter concludes in the journey of collaborative excellence
We're in the process of making some significant changes at Hanson Wade. As part of these changes, our mRNA -Based Therapeutics Searchlight network will be closing down. Â
However, this isn't the end of the road! We are excited to direct you towards other valuable opportunities and resources that Hanson Wade offers. Our commitment to providing industry-leading conferences, data and information products continues, and we believe these will be of great interest and value to you.Â
Related Products:
Hanson Wade specializes in scientific research across various drug modalities, key diseases, and R&D areas.
Browse our different products spanning 200+ conferences, networking groups, bespoke market research services, and databases. Discover how we can help inform your drug development decision-making to accelerate safer, more effective, and accessible drugs to patients in need.
DataÂ
Beacon RNA covers all disease indications and many modalities to provide a detailed landscape of the RNA space including oligonucleotide-based therapies, mRNA-based therapies, ribozyme therapies, gRNA-mediated gene editing therapies and RNA-targeted small molecules.